Allogeneic Retrovirally Transduced, IL-2 and IFN-gamma Secreting Tumor Cell Vaccine in Patients With Hormone-Refractory Prostate Cancer (HRPC)-A Phase I/II Trial
Document type:
Article
Author(s):
Pohla, H; Brill, T; Kubler, H; Buchner, A; van Randenborgh, H; Paul, R; Osthoff, M; Eisele, B; Fend, F; Hartung, R; Schendel, DJ; Gansbacher, B